Resources|Articles|November 8, 2024
mAbs Scale-up video
Author(s)Avantor
Scaling up monoclonal antibody (mAb) production can be challenging, but it doesn't have to slow you down. Explore how our large-volume handling solutions, GMP-grade chemicals and customized solutions for process development, optimization, and validation help you scale up quickly and meet regulatory standards with confidence.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Rare Disease Treatments: Navigating the Economics of Global Innovation
2
Women in STEM: Early Phase Drug Development
3
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
4
PharmTech Weekly Roundup - February 6, 2026
5